"We are the creators of the innovative 'Preventix' laboratory test, dedicated to the science for women's well-being. Our pioneering approach to detecting blood biomarkers for cervical cancer is a milestone in women's healthcare. Furthermore, in our ongoing quest for solutions, we are currently dedicated to the research of 'ATSOVID' and 'ATSOLONA,' driving science and innovation for a healthier world."
The multifunctional shield against respiratory viruses.
Medicine designed to inhibit the SARS COV, Influenza, and respiratory syncytial virus. This medicine has multiple antiviral, anti-inflammatory, and immunomodulatory functions, making it the only effective option on the market to combat a wide spectrum of respiratory viruses.
Medicine designed to inhibit the SARS COV, Influenza, and respiratory syncytial virus. This medicine has multiple antiviral, anti-inflammatory, and immunomodulatory functions, making it the only effective option on the market to combat a wide spectrum of respiratory viruses.
The hope that transforms lives.
State-of-the-art medicine for the treatment of precancerous lesions, HPV, and cervical uterine cancer. Its safety and efficacy have been demonstrated in combating lesions caused by the human papillomavirus, reducing tumor volume by 88% and significantly increasing the life expectancy of patients.
State-of-the-art medicine for the treatment of precancerous lesions, HPV, and cervical uterine cancer. Its safety and efficacy have been demonstrated in combating lesions caused by the human papillomavirus, reducing tumor volume by 88%, and significantly increasing the life expectancy of patients.